P A Marks

1.7k total citations
36 papers, 1.5k citations indexed

About

P A Marks is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, P A Marks has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Physiology. Recurrent topics in P A Marks's work include Erythrocyte Function and Pathophysiology (11 papers), Cancer-related Molecular Pathways (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). P A Marks is often cited by papers focused on Erythrocyte Function and Pathophysiology (11 papers), Cancer-related Molecular Pathways (8 papers) and Toxin Mechanisms and Immunotoxins (5 papers). P A Marks collaborates with scholars based in United States and Italy. P A Marks's co-authors include Richard A. Rifkind, R A Rifkind, Ronald Breslow, Roberta C. Reuben, Richard L. Wife, Hiroaki Kiyokawa, R A Rifkind, Victoria M. Richon, M Terada and Masao Tanaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

P A Marks

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P A Marks United States 20 1.0k 378 309 195 178 36 1.5k
J. G. Holland United States 9 1.1k 1.1× 291 0.8× 304 1.0× 229 1.2× 171 1.0× 13 1.7k
Evan Ingley Australia 25 1.5k 1.5× 368 1.0× 291 0.9× 216 1.1× 436 2.4× 66 2.3k
J F Mushinski United States 19 1.2k 1.2× 286 0.8× 92 0.3× 86 0.4× 299 1.7× 39 1.7k
Daniel J. Price United States 22 1.9k 1.9× 369 1.0× 119 0.4× 93 0.5× 257 1.4× 31 2.4k
Finn C. Wiberg Denmark 21 1.3k 1.3× 448 1.2× 78 0.3× 73 0.4× 201 1.1× 32 2.1k
R A Rifkind United States 13 1.1k 1.1× 341 0.9× 94 0.3× 67 0.3× 103 0.6× 29 1.4k
Roberta Bortul Italy 26 1.7k 1.7× 349 0.9× 97 0.3× 134 0.7× 238 1.3× 60 2.2k
Subal Bishayee United States 18 837 0.8× 302 0.8× 99 0.3× 49 0.3× 215 1.2× 47 1.3k
Silvia Fernández de Mattos Spain 18 1.1k 1.1× 355 0.9× 78 0.3× 136 0.7× 231 1.3× 31 1.6k
Paul Rose United States 17 634 0.6× 329 0.9× 93 0.3× 77 0.4× 205 1.2× 21 1.1k

Countries citing papers authored by P A Marks

Since Specialization
Citations

This map shows the geographic impact of P A Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P A Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P A Marks more than expected).

Fields of papers citing papers by P A Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P A Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P A Marks. The network helps show where P A Marks may publish in the future.

Co-authorship network of co-authors of P A Marks

This figure shows the co-authorship network connecting the top 25 collaborators of P A Marks. A scholar is included among the top collaborators of P A Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P A Marks. P A Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russo, Paul, et al.. (1997). Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.. PubMed. 57(13). 2789–98. 18 indexed citations
2.
Marks, P A, Victoria M. Richon, & Richard A. Rifkind. (1996). Induced differentiation of cancer cells: second generation potent hybrid polar compounds target cell cycle regulators. European Journal of Cancer Prevention. 5. 75–77. 7 indexed citations
3.
Kiyokawa, Hiroaki, et al.. (1993). Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.. Proceedings of the National Academy of Sciences. 90(14). 6746–6750. 41 indexed citations
4.
Leng, Lin, Faquan Yu, Xavier Busquets, et al.. (1993). Differential modulation of protein kinase C isoforms in erythroleukemia during induced differentiation.. PubMed. 53(22). 5554–8. 31 indexed citations
5.
Andreeff, Michael, Richard M. Stone, Joseph Michaeli, et al.. (1992). Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation- inducing agent. Blood. 80(10). 2604–2609. 8 indexed citations
6.
Melloni, E., S. Pontremoli, Bianca Sparatore, et al.. (1990). Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells.. Proceedings of the National Academy of Sciences. 87(12). 4417–4420. 50 indexed citations
7.
Marks, P A & R A Rifkind. (1990). Role of differentiation induction in tumor suppression.. PubMed. 51. 201–16. 3 indexed citations
8.
Chen, Zixing, Joseph Michaeli, P A Marks, & R A Rifkind. (1989). The preliminary study on HMBA-induced differentiation of the drug-pretreated murine erythroleukemia cells. Chinese Journal of Cancer Research. 1(3). 24–28. 1 indexed citations
9.
Melloni, E., S. Pontremoli, M. Michetti, et al.. (1987). Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.. Proceedings of the National Academy of Sciences. 84(15). 5282–5286. 93 indexed citations
10.
Marks, P A, Robert G. Ramsay, M Sheffery, & R A Rifkind. (1987). Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.. PubMed. 251. 253–68. 2 indexed citations
11.
Murate, Takashi, T Kaneda, R A Rifkind, & P A Marks. (1984). Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.. Proceedings of the National Academy of Sciences. 81(11). 3394–3398. 24 indexed citations
12.
Sheffery, M, R A Rifkind, & P A Marks. (1983). Hexamethylenebisacetamide-resistant murine erythroleukemia cells have altered patterns of inducer-mediated chromatin changes.. Proceedings of the National Academy of Sciences. 80(11). 3349–3353. 16 indexed citations
13.
Banks, J., et al.. (1982). Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.. Proceedings of the National Academy of Sciences. 79(2). 471–475. 83 indexed citations
14.
Fibach, Eitan, P A Marks, & R A Rifkind. (1980). Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells.. Proceedings of the National Academy of Sciences. 77(7). 4152–4155. 26 indexed citations
15.
Gambari, Roberto, P A Marks, & R A Rifkind. (1979). Murine erythroleukemia cell differentiation: relationship of globin gene expression and of prolongation of G1 to inducer effects during G1/early S.. Proceedings of the National Academy of Sciences. 76(9). 4511–4515. 58 indexed citations
16.
Rifkind, R A & P A Marks. (1978). Regulation of differentiation in transformed erythroid cells.. PubMed. 4(1-2). 189–206. 5 indexed citations
17.
Fibach, Eitan, Hiroshi Yamasaki, Weinstein Ib, P A Marks, & R A Rifkind. (1978). Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation.. PubMed. 38(11 Pt 1). 3685–8. 48 indexed citations
18.
Kim, HC, et al.. (1976). Isolation and in vitro differentiation of human erythroid precursor cells. Blood. 47(5). 767–776. 5 indexed citations
19.
Tanaka, Masao, Joseph Levy, M Terada, et al.. (1975). Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds.. Proceedings of the National Academy of Sciences. 72(3). 1003–1006. 191 indexed citations
20.
Marks, P A. (1972). Differentiation of erythroid cells.. PubMed. 66. 43–73. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. G. Holland Breakdown of academic impact, for papers by Evan Ingley Breakdown of academic impact, for papers by J F Mushinski Breakdown of academic impact, for papers by Daniel J. Price Breakdown of academic impact, for papers by Finn C. Wiberg Breakdown of academic impact, for papers by R A Rifkind Breakdown of academic impact, for papers by Roberta Bortul Breakdown of academic impact, for papers by Subal Bishayee Breakdown of academic impact, for papers by Silvia Fernández de Mattos Breakdown of academic impact, for papers by Paul Rose
Rankless by CCL
2026